Epigenetics advancing personalized nanomedicine in cancer therapy

被引:29
作者
Liu, Shujun [1 ]
机构
[1] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA
关键词
Epigenetics; Biomarkers; Targeted therapy; Nanotechnology; Nanoparticles; Drug delivery; Personalized medicine; Nanomedicine; Personalized nanomedicine; ACUTE MYELOID-LEUKEMIA; DNA METHYLTRANSFERASES DNMT1; BREAST-CANCER; LUNG-CANCER; PROMOTER HYPERMETHYLATION; COLORECTAL-CANCER; MULTIPLE GENES; CPG-ISLAND; HISTONE MODIFICATIONS; METHYLATION;
D O I
10.1016/j.addr.2012.08.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Personalized medicine aims to deliver the right drug to a right patient at the right time. It offers unique opportunities to integrate new technologies and concepts to disease prognosis, diagnosis and therapeutics. While selective personalized therapies are conceptually impressive, the majority of cancer therapies have dismal outcome. Such therapeutic failure could result from no response, drug resistance, disease relapse or severe side effect from improper drug delivery. Nanomedicine, the application of nanotechnology in medicine, has a potential to advance the identification of diagnostic and prognostic biomarkers and the delivery of right drug to disease sites. Epigenetic aberrations dynamically contribute to cancer pathogenesis. Given the individualized traits of epigenetic biomarkers, epigenetic considerations would significantly refine personalized nanomedicine. This review aims to dissect the interface of personalized medicine with nanomedicine and epigenetics. I will outline the progress and highlight challenges and areas that can be further explored perfecting the personalized health care. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:1532 / 1543
页数:12
相关论文
共 170 条
[1]   Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics [J].
Abdolmaleky, Hamid Mostafavi ;
Zhou, Jing-Rong ;
Thiagalingam, Sam ;
Smith, Cassandra L. .
PHARMACOGENOMICS, 2008, 9 (12) :1809-1823
[2]   New nomenclature for chromatin-modifying enzymes [J].
Allis, C. David ;
Berger, Shelley L. ;
Cote, Jacques ;
Dent, Sharon ;
Jenuwien, Thomas ;
Kouzarides, Tony ;
Pillus, Lorraine ;
Reinberg, Danny ;
Shi, Yang ;
Shiekhattar, Ramin ;
Shilatifard, Ali ;
Workman, Jerry ;
Zhang, Yi .
CELL, 2007, 131 (04) :633-636
[3]   Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors [J].
Andersen, Jannik N. ;
Sathyanarayanan, Sriram ;
Di Bacco, Alessandra ;
Chi, An ;
Zhang, Theresa ;
Chen, Albert H. ;
Dolinski, Brian ;
Kraus, Manfred ;
Roberts, Brian ;
Arthur, William ;
Klinghoffer, Rich A. ;
Gargano, Diana ;
Li, Lixia ;
Feldman, Igor ;
Lynch, Bethany ;
Rush, John ;
Hendrickson, Ronald C. ;
Blume-Jensen, Peter ;
Paweletz, Cloud P. .
SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (43)
[4]  
[Anonymous], ONCOLOGY WILLISTON P
[5]   Epigenetic transgenerational actions of endocrine disruptors and mate fertility [J].
Anway, MD ;
Cupp, AS ;
Uzumcu, M ;
Skinner, MK .
SCIENCE, 2005, 308 (5727) :1466-1469
[6]   Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge [J].
Arvizo, Rochelle R. ;
Rana, Subinoy ;
Miranda, Oscar R. ;
Bhattacharya, Resham ;
Rotello, Vincent M. ;
Mukherjee, Priyabrata .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2011, 7 (05) :580-587
[7]   Effect of Nanoparticle Surface Charge at the Plasma Membrane and Beyond [J].
Arvizo, Rochelle R. ;
Miranda, Oscar R. ;
Thompson, Michael A. ;
Pabelick, Christina M. ;
Bhattacharya, Resham ;
Robertson, J. David ;
Rotello, Vincent M. ;
Prakash, Y. S. ;
Mukherjee, Priyabrata .
NANO LETTERS, 2010, 10 (07) :2543-2548
[8]   Genetic Interactions in Cancer Progression and Treatment [J].
Ashworth, Alan ;
Lord, Christopher J. ;
Reis-Filho, Jorge S. .
CELL, 2011, 145 (01) :30-38
[9]   MS-qFRET: A quantum dot-based method for analysis of DNA methylation [J].
Bailey, Vasudev J. ;
Easwaran, Hariharan ;
Zhang, Yi ;
Griffiths, Elizabeth ;
Belinsky, Steven A. ;
Herman, James G. ;
Baylin, Stephen B. ;
Carraway, Hetty E. ;
Wang, Tza-Huei .
GENOME RESEARCH, 2009, 19 (08) :1455-1461
[10]   Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs [J].
Barter, M. J. ;
Bui, C. ;
Young, D. A. .
OSTEOARTHRITIS AND CARTILAGE, 2012, 20 (05) :339-349